We are live on ! Find out more
ANIP icon

ANI Pharmaceuticals

126 hedge funds and large institutions have $330M invested in ANI Pharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 50 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

13% more capital invested

Capital invested by funds: $293M → $330M (+$36.9M)

5% more funds holding

Funds holding: 120126 (+6)

1.61% more ownership

Funds ownership: 57.3%58.92% (+1.6%)

34% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 50

58% less call options, than puts

Call options by funds: $726K | Put options by funds: $1.72M

Holders
126
Holders Change
+6
Holders Change %
+5%
% of All Funds
2.17%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
17
Increased
33
Reduced
50
Closed
10
Calls
$726K
Puts
$1.72M
Net Calls
-$990K
Net Calls Change
+$255K
Name Holding Trade Value Shares
Change
Change in
Stake
CAPTRUST Financial Advisors
126
CAPTRUST Financial Advisors
North Carolina
-$19K -640 Closed
Rockefeller Capital Management
127
Rockefeller Capital Management
New York
-$1.3K -38 -86%
MAM
128
Meeder Asset Management
Ohio
+$34 +1 +50%
FMII
129
Farmers & Merchants Investments Inc
Nebraska
+$274 +8 New